A recent survey by DePaul University asked medical schools if they were meeting clinical, curricular, and research standards for teaching ME/CFS. Only four of the 71 responding schools (5.6%) met criteria for all three domains.
This is a major problem because 1 million Americans and 17 million people are severely ill with this disease, which experts conclude is as disabling as late-stage AIDS, cancer, and congestive heart failure. Federal funding from the NIH is stagnant at just $3 million-$6 million per year.
Patients can't wait for the government to act. They need quality care NOW. Wait times to see ME/CFS experts can be several years long. That's why the Blue Ribbon Fellowship seeks to enable medical students to spend their summers studying at top neuro-immune institutes and to publish their research. It's time to inject new vigor into this field and train the next generation of ME/CFS clinicians.
We will be speaking at the National Press Club in Washington, D.C. on Friday, January 24th, with Andreas Kogelnik, MD, PhD, a fierce supporter of this initiative and a world expert on neuro-immune diseases.
For more info, visit: